Featured
EU Bonds: A safe haven for institutional investors?
For the first time, the EU issued bonds in October 2020 to mitigate the damage caused by the COVID-19 pandemic. The new EU bonds met with record demand from institutional investors. A second tranche will follow in the first half of 2021. According to information from the EU Commission, EU Sure bonds with a value of up to $118 billion (€100 billion) will be issued as social bonds.
The first two bonds to combat the Coronavirus pandemic were launched on October 20th, 2020, with great success: investors wanted to invest a total of $275 billion (€233 billion) in these bonds. Securities worth $20 billion (€17 billion) were placed on the market. The securities were thus more than 13 times oversubscribed – a record for bonds issued in the eurozone.
With this issue, the EU Commission had taken the first step towards playing in the top league on the international capital markets, commented EU Budget Commissioner Johannes Hahn. “The fact that the bonds were social bonds helped to stimulate the interest of investors who want to support the member states in securing jobs in these difficult times,” said Hahn.
Read more about EU bonds to combat the pandemic and find the most important financial news with our companion app, Born2Invest.
EU bonds to secure employment
The Commission had issued the social bonds under the “Sure” instrument. The funds are to be used to secure jobs. The loans are intended to help the member states to cover costs arising from national short-time working schemes and similar measures.
Brussels issued two EU bonds: One with a term of 10 years for $11.8 billion (€10 billion) and one with a term of 20 years for $8.3 billion (€7 billion). The oversubscription was reflected in favorable conditions: the 10-year bond was quoted at 3 basis points and the 20-year bond at 14 basis points above the mid-swap rate. The final new issue premium is estimated at 1 and 2 basis points for the respective tranches, the Commission said.
EU bonds with good ratings
According to Franklin Templeton, the successful market placement demonstrates the interest of institutional investors in ESG-compliant investments. The COVID-19 pandemic has further increased attention to this topic. Although regional bonds have been issued in Europe before, these new social bonds represent the first EU-wide issue. The plus point: the bonds are of high quality with AAA ratings from various rating agencies. “We believe that many investors both inside and outside Europe will buy these bonds to diversify individual country risks,” said David Zahn, bond expert at the asset manager. In view of the good rating, the securities should serve as a safe haven in the future
A second, larger tranche should follow in the first half of 2021, according to EU Budget Commissioner Johannes Hahn
According to information from the EU Commission, EU Sure bonds with a value of up to $118 billion (€100 billion) will be issued as social bonds. For this purpose, an independently assessed framework for social bonds has been set up. Investors should be given security that the collected funds really serve a social cause.
This announcement followed the Council’s approval to provide financial assistance to 16 member states under the “Sure” instrument to protect jobs and workers. The funds raised are disbursed as loans to the Member States. The federal states are to be supported with the funds to cover costs that arose from the financing of national short-time working regulations and similar measures in response to the corona pandemic. Certain health-related measures – especially in the workplace – can also be financed through Sure.
__
(Featured image by Capri23auto via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in dpn, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Biotech6 days ago
Novo Nordisk: Ozempic Gets Positive Evaluation for Kidney Treatment
-
Impact Investing2 weeks ago
Hera Receives 10 Million Euros from the PNRR for Agrivoltaics
-
Crypto3 days ago
Blackrock Just Launched the RWA Tokenization Snowball. Here’s How to Profit With SurancePlus [NASDAQ: OXBR]
-
Cannabis1 week ago
Coffee Shops in Only 10 Dutch Cities Will Sell Legal Cannabis from April 2025